The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDuke Capital Regulatory News (DUKE)

Share Price Information for Duke Capital (DUKE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 31.25
Bid: 31.00
Ask: 31.50
Change: 0.25 (0.81%)
Spread: 0.50 (1.613%)
Open: 31.25
High: 31.30
Low: 31.25
Prev. Close: 31.00
DUKE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Follow-on contribution to royalty partner

16 Mar 2020 07:00

RNS Number : 1877G
Duke Royalty Limited
16 March 2020
 

16 March 2020

 Duke Royalty Limited

("Duke Royalty", "Duke" or the "Company")

 

£1 Million Follow-On Contribution with Existing Royalty Partner

 

Duke Royalty Limited (AIM: DUKE), a provider of alternative capital solutions to a diversified range of profitable and long-established businesses in Europe and abroad, is pleased to announce a follow-on investment of £1 million into its existing royalty partner Lynx Equity (UK) Ltd. ("Lynx UK").

 

Lynx UK will use this contribution from Duke towards the acquisition of Danish manufacturer, Arkas A/S ("Arkas"), which was agreed in February 2020. This acquisition is Lynx UK's sixth acquisition within the UK and Europe and this follow-on investment further diversifies both Duke's portfolio and Lynx UK's revenue and EBITDA base.

 

With Duke's investment in Lynx UK now increased to £13 million, the Company is entitled to higher distributions of £1.7 million per annum, beginning in April 2020, representing a pro forma cash yield of 13.0% on total invested capital. This follow-on transaction will also increase the security of Duke's investment. All other terms of the £1 million contribution are the same as Duke's previous investment made into Lynx UK.

 

Neil Johnson, CEO of Duke Royalty, said:

"This latest deal increases our royalty income and further diversifies our portfolio, but most importantly, it improves the royalty coverage ratio for the portfolio. Lynx UK has a strong financial track record which has facilitated two consecutive positive annual adjustments previously. Lynx's focus on acquiring profitable companies at a reasonable multiple is key to their success over the last 12 years. This follow-on epitomises our strategy to become a long-term funding partner to businesses in the UK and Europe."

 

About Arkas

 

Arkas is a private, profitable manufacturer of bespoke garage doors and single doors for commercial and residential applications. Founded in 1986, Arkas is the only manufacturer of exclusively Danish-made wood doors and garage doors and has built its reputation based on its high level of quality, customisation and fast turnaround. Currently, Arkas products are sold through over 400 points of sale across Denmark including the country's leading timber merchants.

 

Duke Royalty Portfolio

Following this follow-on investment into Lynx, Duke's portfolio of core royalty investments is as follows:

 

Royalty Partner

Total Investment Amount

Date of Initial Investment

Temarca B.V.

€14,682,000

April 2017

Berkley Recruitment (Group) Limited

€1,300,000

June 2017

Welltel (Ireland) Limited

£8,128,000

June 2017

Lynx Equity (UK) Limited

£13,000,000

October 2017

Xtremepush Limited

£2,000,000

February 2018

Trimite Global Coatings Limited

£11,000,000

March 2018

United Glass Group Ltd (formerly Brownhills)

£7,500,000

April 2018

Step Investments Limited

£4,240,000

June 2018

BHPC Limited

€4,600,000

August 2018

InterHealth Canada

£10,000,000

August 2018

Brightwater Selection (Ireland) Limited

£9,355,000

September 2018

MRDB Holdings Limited Group

£10,000,000

February 2019

 

 

**ENDS**

 

 

For further information, please contact www.dukeroyalty.com, or contact:

 

Duke Royalty Limited

Neil Johnson / Charlie Cannon-Brookes / Hugo Evans

+44 (0) 1481 741 240

Cenkos Securities plc

(Nominated Adviser and Broker)

Stephen Keys / Callum Davidson /

Julian Morse / Michael Johnson

+44 (0) 207 397 8900

Newgate Communications

(PR)

Elisabeth Cowell / Ian Silvera / Megan Kovach

+44 (0) 20 3757 6880

Dukeroyalty@newgatecomms.com

 

About Duke Royalty

 

Duke Royalty Limited provides alternative capital solutions to a diversified range of profitable and long-established businesses in Europe and abroad. Duke Royalty's experienced team provide financing solutions to private companies that are in need of capital but whose owners wish to maintain equity control of their business. Duke Royalty's royalty investments are intended to provide robust, stable, long term returns to its shareholders. Duke Royalty is listed on the AIM market under the ticker DUKE and is headquartered in Guernsey.

 

Royalty Partner - Lynx UK

 

Duke entered into a royalty agreement with Lynx UK, a wholly-owned subsidiary of Lynx Equity Limited ("Lynx (Canada)"), on October 5, 2017 to finance Lynx UK's acquisition strategy as its "preferred European capital provider" up to a total investment pool of £15m in tranches on a drawdown basis with proceeds being used to acquire target companies in Europe.

 

Lynx UK's European portfolio currently includes Denmark's PartnerService, Sundby Trapper and Arkas, and UK's Signalhome, Label Express and Day2 Interiors.

 

Lynx (Canada) is a Toronto-based private company founded over 12 years ago with a portfolio of more than 50 operating companies and revenue exceeding C$500 million, that seeks to acquire, own, and operate mature, old-economy businesses, with no intent of sale. Lynx Equity's portfolio businesses operate in a diverse range of industries, and typically produce between $750,000 to $2,500,000 of EBITDA.

 

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCKKPBBFBKDBND
Date   Source Headline
3rd Apr 20247:00 amRNSFollow-On Investment into Existing Capital Partner
2nd Apr 20247:00 amRNSNew Capital Partner - Integrum Care
28th Mar 20247:00 amRNSTrading and Operational Update
21st Mar 20247:00 amRNSInterim Dividend and Dividend Declaration
7th Mar 20247:00 amRNSSuccessful Exit of Investment in Fabrikat
6th Mar 20247:00 amRNSSuccessful Exit of Investment
4th Mar 20247:00 amRNSIncreased Equity Stake in United Glass Group
21st Feb 202411:57 amRNSName Change Effective
20th Feb 202412:08 pmRNSResult of General Meeting & Change of Name
5th Feb 20247:00 amRNSProposed Change of Name, Website and Messaging
29th Dec 20237:00 amRNSTrading Update and Follow-on Investment
19th Dec 20237:00 amRNSInterim Dividend and Dividend Declaration
29th Nov 20237:00 amRNSUpdate re. Change of Name of Nominated Adviser
22nd Nov 20237:00 amRNSFinancial Year 2024 Interim Results
21st Sep 20237:00 amRNSInterim Dividend and Dividend Declaration
13th Sep 20237:00 amRNSTrading Update
2nd Aug 20234:51 pmRNSResult of Annual General Meeting
31st Jul 20237:00 amRNSNew Royalty Agreement
28th Jul 20237:00 amRNSDirector/PDMR Dealings
20th Jul 20237:00 amRNSFollow-On Investment into Existing Royalty Partner
4th Jul 20237:00 amRNSFinal Results for the year ended 31 March 2023
3rd Jul 20237:00 amRNSFollow-On Investment into Existing Royalty Partner
26th Jun 20237:00 amRNSFollow-On Investment into Existing Royalty Partner
15th Jun 20237:00 amRNSInterim Dividend and Dividend Declaration
9th Jun 20237:00 amRNSNotice of Results
1st Jun 20237:00 amRNSTrading Update
25th May 20237:00 amRNSDirectors' Dealings
24th May 20237:00 amRNSSuccessful Exit of Investment in Royalty Partner
22nd Mar 20237:00 amRNSInterim Dividend and Dividend Declaration
7th Mar 20237:00 amRNSNew Royalty Agreement
3rd Mar 20237:00 amRNSTrading Update
21st Feb 20237:00 amRNSFollow-On Investment into Existing Royalty Partner
16th Jan 20237:00 amRNSClosing of New Credit Facility
15th Dec 20223:35 pmRNSInterim Dividend and Dividend Declaration
13th Dec 20227:00 amRNSFollow-On Investment into Existing Royalty Partner
12th Dec 20227:00 amRNSRefinance and Upsize of Credit Facility
1st Dec 20227:01 amRNSTrading Update
1st Dec 20227:00 amRNS2023 Interim Results
29th Nov 202212:38 pmRNSResult of Annual General Meeting
25th Nov 20227:00 amRNSNew Royalty Agreement
14th Nov 20227:00 amRNSNotice of AGM and Notice of Interim Results
14th Oct 20227:00 amRNSPSAs, Issue of Equity & Director/PDMR Dealings
22nd Sep 20227:00 amRNSInterim Dividend and Dividend Declaration
13th Sep 20229:09 amRNSPublication of Annual Report & Accounts
9th Sep 20227:00 amRNSPostponement of Presentation
8th Sep 20227:00 amRNSFinal Results for the year ended 31 March 2022
31st Aug 20225:04 pmRNSHolding(s) in Company
30th Aug 20223:07 pmRNSHolding(s) in Company
5th Aug 20227:00 amRNSNotice of Results and Presentations
4th Aug 20227:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.